2018
DOI: 10.1002/cti2.1010
|View full text |Cite
|
Sign up to set email alerts
|

Vaccinating for natural killer cell effector functions

Abstract: Vaccination has proved to be highly effective in reducing global mortality and eliminating infectious diseases. Building on this success will depend on the development of new and improved vaccines, new methods to determine efficacy and optimum dosing and new or refined adjuvant systems. NK cells are innate lymphoid cells that respond rapidly during primary infection but also have adaptive characteristics enabling them to integrate innate and acquired immune responses. NK cells are activated after vaccination a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
26
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(26 citation statements)
references
References 112 publications
0
26
0
Order By: Relevance
“…Our finding that expression of PRV gB triggers NK cell cytotoxicity increases our understanding of the interaction of alphaherpesviruses with this particularly important immune cell population and may lead to clinical applications. Indeed, activation of NK cells has been proposed as a valuable strategy in the design of alphaherpesvirus vaccines (25)(26)(27)(28)(29)(30)(31). In addition, NK cell-mediated elimination of virus-infected cells has been reported to interfere with efficient tumor cell lysis by HSV-based oncolytic vectors in a mouse model of glioblastoma (32).…”
Section: Discussionmentioning
confidence: 99%
“…Our finding that expression of PRV gB triggers NK cell cytotoxicity increases our understanding of the interaction of alphaherpesviruses with this particularly important immune cell population and may lead to clinical applications. Indeed, activation of NK cells has been proposed as a valuable strategy in the design of alphaherpesvirus vaccines (25)(26)(27)(28)(29)(30)(31). In addition, NK cell-mediated elimination of virus-infected cells has been reported to interfere with efficient tumor cell lysis by HSV-based oncolytic vectors in a mouse model of glioblastoma (32).…”
Section: Discussionmentioning
confidence: 99%
“…CIML NK cells have been described in a number of different in vitro models and postinfection and vaccination (reviewed in Ref. 22,23). Similarly to in vitro priming with cytokines, in vitro priming with inactivated H1N1 virus and TIV vaccination led to enhanced NK cell responses to cytokines alone (9), suggesting that antiviral cytokine stimulation is sufficient to generate CIML NK cells.…”
Section: Discussionmentioning
confidence: 99%
“…46 Furthermore, following infection or vaccination, NK cells themselves can develop into long-lived memory cells capable of more robust cytotoxic responses and higher IFN-c production upon rechallengein some cases in an antigen-specific mannercompared with naive NK cells. 47,48 Most interestingly, NKp46 and NKp30, two key NK cell cytotoxicity receptors, were reported to act as fungicidal PRRs for Cryptococcus and Candida, 30,31,49 posing the exciting possibility that pathogen-specific NK cell memory, the existence of which has already been demonstrated for viruses, 47 could develop against fungi. IL-12, IL-15 and IL-18) alone were found to be capable of supporting splenic NK cell memory properties in the absence of antigen; these cytokine-induced memory-like NK cells can be induced by vaccination in response to CD4 + T-cellderived IL-2 and myeloid cell-derived IL-12 and type I interferons, and have been implicated in the enhancement of NK cell function ex vivo.…”
Section: Discussionmentioning
confidence: 99%
“…IL-12, IL-15 and IL-18) alone were found to be capable of supporting splenic NK cell memory properties in the absence of antigen; these cytokine-induced memory-like NK cells can be induced by vaccination in response to CD4 + T-cellderived IL-2 and myeloid cell-derived IL-12 and type I interferons, and have been implicated in the enhancement of NK cell function ex vivo. 47,48 Most interestingly, NKp46 and NKp30, two key NK cell cytotoxicity receptors, were reported to act as fungicidal PRRs for Cryptococcus and Candida, 30,31,49 posing the exciting possibility that pathogen-specific NK cell memory, the existence of which has already been demonstrated for viruses, 47 could develop against fungi. Given our own work developing an anti-Sporothrix vaccine, 50,51 the above underlines the huge clinical value of a better understanding of the NK-Sporothrix relationship.…”
Section: Discussionmentioning
confidence: 99%